.
MergerLinks Header Logo

New Deal


Announced

Kijani to acquire Geneslab from Actis.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Sources

Edit

Tags

Edit

Majority

Single Bidder

Mbo

Domestic

Friendly

Pending

Private Equity

Test Inspection and Certification (TIC)

Acquisition

Brazil

testing inspection and certification

Private

Synopsis

Edit

Kijani, an asset manager specializing in national agribusiness, agreed to acquire Geneslab, a provider of testing, inspection and certification services, from Actis, a global investment firm. Financial terms were not disclosed. “It is strategic both for us at Kijani and for Geneslab. In addition to continuing the development of the company, we will have the participation of the founding partners on a daily basis. This operation represents the essence of what we at Kijani preach in our investment theses: empowering great entrepreneurs. We will be present, adding both our experience in management – ​​strengthening governance, professionalization and capital structure – and our vast network of relationships in agribusiness, in order to support entrepreneurs in what they do best, building great businesses," Bruno Santana, Kijani CEO and Founder.

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US